Research findings, pricing news, and vendor analysis across the peptide market.
Showing 31 to 60 of 181
A reaction does not prove a bad peptide batch. Use timing, concentration math, batch recurrence, vial evidence, and lot-matched COAs to separate expected compound effects from administration variables and product-quality concerns before replacing a vial.
Read more →Epitalon, MOTS-c, NAD+, and SS-31 occupy different longevity research lanes. Compare their evidence, biological-age tracking fit, current price per mg, vendor testing depth, and best buying use case before checkout.
Read more →KPV, BPC-157, and TB-500 occupy different inflammation and recovery research lanes. Compare the evidence, current price per mg, vendor testing depth, and best buying fit before checkout.
Read more →Pinealon and Epitalon come from the same short-peptide research tradition, but they are different sequences with different research lanes and prices. Compare EDR versus AEDG, current cost per mg, evidence depth, and the COA checks that matter before buying.
Read more →Tesamorelin prices vary sharply by vial size, discount, and testing proof. Compare current 2026 cost per mg, the strongest vendor checkpoints, and the human visceral-fat evidence before buying.
Read more →Retatrutide results can look slow or inconsistent because trial averages hide individual variation, short-term scale noise, concentration errors, and product-quality problems. Use this checklist to separate timing, fatigue, measurement, and vial-proof questions before comparing a replacement lot or vendor.
Read more →KT Peptides has a live 79-product catalog and unusually low 10-vial pack pricing, but its public proof needs careful review. Here is what the posted COAs show, what they leave unverified, and how buyers can compare price per verified milligram before ordering.
Read more →Cagrilintide buyers can use human trial ranges to understand the evidence, then compare 10 mg vial math, current price per mg, discount codes, and lot-specific COA proof before buying.
Read more →PT-141 buyers need to separate the studied 1.75 mg bremelanotide reference dose from research-vial concentration math. This guide covers timing, 10 mg reconstitution examples, current cost per 1.75 mg equivalent, and the COA checks to make before buying.
Read more →AOD-9604 buyers need to separate commonly reported subcutaneous protocols from the oral and intravenous doses actually studied in humans. This guide provides 5 mg vial math, current price-per-mg comparisons, trial data, and the COA checks to use before buying.
Read more →GHK-Cu injection-site burning can reflect concentration, product quality, diluent, handling, or technique, and the symptom alone cannot identify the cause. This guide shows the concentration math, red flags, COA checks, and current price-per-mg comparisons buyers should review before choosing a vial.
Read more →TB-500 buyers need three numbers before comparing a vial: exact product identity, concentration after reconstitution, and delivered cost per verified milligram. This guide explains reported protocol ranges, 5 mg and 10 mg vial math, current prices, and the COA checks that separate a strong buy from a cheap label.
Read more →BPC-157 and TB-500 are the two recovery peptides dog owners compare most often. This guide explains how their research, reported veterinary uses, weight-based planning, prices, and COA checks differ before a licensed veterinarian helps choose a path.
Read more →A 10 mg vial can produce very different concentrations depending on the amount of bacteriostatic water added. This chart converts 1 to 5 mL dilution choices into mg/mL, mcg per U-100 syringe unit, and example draw-unit math, then routes buyers to current prices and verified vendors.
Read more →CJC-1295 with DAC and CJC-1295 without DAC share a core peptide but differ sharply in duration, labeling, research evidence, and cost math. This guide shows buyers how to verify the exact variant, compare current price per mg, and avoid paying for an ambiguously labeled vial.
Read more →Semax is most commonly researched intranasally, but spray concentration, peptide variant, bottle output, and vial price can make two products hard to compare. Use this guide to check the math, compare current price per mg, and verify the product before buying.
Read more →GHK-Cu is the cosmetic peptide with the clearest topical skin evidence behind the looksmaxxing trend. Compare formats, clinical findings, current price per mg, and vendor proof before choosing what to buy.
Read more →Blue color can be consistent with the GHK-Cu copper complex, but it cannot authenticate a vial. Use this practical checklist to evaluate appearance, lot-matched testing, measured fill, vendor transparency, and price before buying.
Read more →SLU-PP-915 and MOTS-c reach the endurance research lane through different mechanisms. Compare the mouse evidence, current MOTS-c prices, product identity, and COA proof before choosing a research buy.
Read more →SS-31 prices in PeptidePub’s August 2026 catalog range from $2.80 to $19.30 per mg before discounts. Compare vial sizes, after-code value, COA proof, and benefit fit against MOTS-c before buying.
Read more →Selank buyers face three decisions at once: nasal spray or vial, native Selank or a modified analog, and which offer has the best verified value. Compare the evidence, labels, COAs, and current price per mg before buying.
Read more →GHK-Cu and minoxidil target different parts of the hair-growth conversation, but direct evidence for the combination is limited. Compare what the studies actually tested, which GHK-Cu format fits the goal, and how to buy by identity, COA proof, and price per mg.
Read more →No controlled human study shows that BPC-157 causes cancer, but its effects on blood-vessel signaling make the question worth answering precisely. Here is what the angiogenesis research shows, what it does not prove, and how buyers can compare BPC-157 by price and testing proof.
Read more →Understand the BPC-157 ranges most often reported online, how 5 mg and 10 mg vial math works, and what each measured amount costs across current vendors. Compare price, COA proof, and vial size before buying.
Read more →Retatrutide combines GLP-1, GIP, and glucagon receptor activity in one molecule. Learn what each target contributes and what Phase 2 and Phase 3 evidence can actually establish.
Read more →The best topical copper peptide depends on whether you want disclosed GHK-Cu strength, a low cost per mL, or a broader peptide formula. Compare leading serums by exact copper-peptide identity, concentration disclosure, price, and product-level evidence before buying.
Read more →New to peptides? Use this first-vial checklist to choose the right compound, compare price per mg, verify the COA, understand vial math, and buy from a vendor with proof.
Read more →MOTS-c buyers commonly ask where a subcutaneous injection goes, why site rotation matters, and how vial concentration changes the volume being handled. This practical guide connects general injection-site guidance with reconstitution math, current MOTS-c prices, and the COA checks to run before buying.
Read more →Oral BPC-157 capsules win on convenience, while lyophilized vials make identity and price-per-mg comparisons easier. Compare acetate versus arginate labels, current vial prices, and the proof each format should provide before buying.
Read more →The best Selank purchase combines the right format with a competitive cost per mg and lot-matched testing. Compare current vial prices, nasal versus lyophilized formats, identity details, and COA checks before choosing a source.
Read more →STOP PIECING IT TOGETHER
We wrote the shortcut: five books, 55 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.
